Skip to main content

Advertisement

Log in

Resting heart rate as a prognostic factor for mortality in patients with breast cancer

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Although elevated resting heart rate (RHR) has been shown to be associated with mortality in the general population and patients with certain diseases, no study has examined this association in patients with breast cancer. A total of 4786 patients with stage I–III breast cancer were retrospectively selected from the Severance hospital breast cancer registry in Seoul, Korea. RHR was measured at baseline and the mean follow-up time for all patients was 5.0 ± 2.5 years. Hazard ratios (HRs) with 95 % confidence intervals (CIs) were calculated using Cox regression models. After adjustment for prognostic factors, patients in the highest quintile of RHR (≥85 beat per minute (bpm)) had a significantly higher risk of all-cause mortality (HR: 1.57; 95 %CI 1.05–2.35), breast cancer-specific mortality (HR: 1.69; 95 %CI 1.07–2.68), and cancer recurrence (HR: 1.49; 95 %CI 0.99–2.25), compared to those in the lowest quintile (≤67 bpm). Moreover, every 10 bpm increase in RHR was associated with 15, 22, and 6 % increased risk of all-cause mortality, breast cancer-specific mortality, and cancer recurrence, respectively. However, the association between RHR and cancer recurrence was not statistically significant (p = 0.26). Elevated RHR was associated with an increased risk of mortality in patients with breast cancer. The findings from this study suggest that RHR may be used as a prognostic factor for patients with breast cancer in clinical settings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Anselmino M, Öhrvik J, Rydén L (2010) Resting heart rate in patients with stable coronary artery disease and diabetes: a report from the euro heart survey on diabetes and the heart. Eur Heart J: ehq368

  2. Bemelmans RH, van der Graaf Y, Nathoe HM, Wassink AM, Vernooij JW, Spiering W, Visseren FL, Group SS (2013) The risk of resting heart rate on vascular events and mortality in vascular patients. Int J Cardiol 168:1410–1415

    Article  PubMed  Google Scholar 

  3. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L (1999) Influence of heart rate on mortality in a French population role of age, gender, and blood pressure. Hypertension 33:44–52

    Article  CAS  PubMed  Google Scholar 

  4. Böhm M, Cotton D, Foster L, Custodis F, Laufs U, Sacco R, Bath PM, Yusuf S, Diener H-C (2012) Impact of resting heart rate on mortality, disability and cognitive decline in patients after ischaemic stroke. Eur Heart J 33:2804–2812

    Article  PubMed  Google Scholar 

  5. Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators S (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886–894

    Article  PubMed  Google Scholar 

  6. Diaz A, Bourassa MG, Guertin MC, Tardif JC (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26:967–974. doi:10.1093/eurheartj/ehi190

    Article  PubMed  Google Scholar 

  7. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, BERKSON DM, LEPPER M, SCHOENBERGER JA, LINDBERG HA (1980) Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112:736–749

    CAS  PubMed  Google Scholar 

  8. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386

    Article  CAS  PubMed  Google Scholar 

  9. Fox K, Bousser M-G, Amarenco P, Chamorro A, Fisher M, Ford I, Hennerici MG, Mattle HP, Rothwell PM, Investigators PS (2013) Heart rate is a prognostic risk factor for myocardial infarction: a post hoc analysis in the PERFORM (Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack) study population. Int J Cardiol 168:3500–3505

    Article  PubMed  Google Scholar 

  10. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372:817–821

    Article  PubMed  Google Scholar 

  11. Fujiura Y, Adachi H, Tsuruta M, Jacobs DR, Hirai Y, Imaizumi T (2001) Heart rate and mortality in a Japanese general population: an 18-year follow-up study. J Clin Epidemiol 54:495–500

    Article  CAS  PubMed  Google Scholar 

  12. Gillman MW, Kannel WB, Belanger A, D’Agostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the framingham study. Am Heart J 125:1148–1154

    Article  CAS  PubMed  Google Scholar 

  13. Greenland P, Daviglus ML, Dyer AR, Liu K, Huang CF, Goldberger JJ, Stamler J (1999) Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the chicago heart association detection project in industry. Am J Epidemiol 149:853–862

    Article  CAS  PubMed  Google Scholar 

  14. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC (2010) American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J clin oncol 28:2784–2795. doi:10.1200/jco.2009.25.6529

    Article  PubMed  PubMed Central  Google Scholar 

  15. Hillis G, Woodward M, Rodgers A, Chow C, Li Q, Zoungas S, Patel A, Webster R, Batty G, Ninomiya T (2012) Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia 55:1283–1290

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Jensen MT, Marott JL, Allin KH, Nordestgaard BG, Jensen GB (2012) Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the copenhagen city heart study. Eur J of preventive cardiol 19:102–108

    Article  Google Scholar 

  17. Jensen MT, Suadicani P, Hein HO, Gyntelberg F (2013) Elevated resting heart rate, physical fitness and all-cause mortality: a 16-year follow-up in the copenhagen male study. Heart 99:882–887

    Article  PubMed  PubMed Central  Google Scholar 

  18. Jouven X, Escolano S, Celermajer D, Empana JP, Bingham A, Hermine O, Desnos M, Perier MC, Marijon E, Ducimetiere P (2011) Heart rate and risk of cancer death in healthy men. PLoS ONE 6:e21310. doi:10.1371/journal.pone.0021310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Jouven X, Zureik M, Desnos M, Guérot C, Ducimetière P (2001) Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 50:373–378

    Article  CAS  PubMed  Google Scholar 

  20. Kannel WB, Kannel C, Paffenbarger RS, Cupples LA (1987) Heart rate and cardiovascular mortality: the framingham study. Am Heart J 113:1489–1494

    Article  CAS  PubMed  Google Scholar 

  21. Kolloch R, Legler UF, Champion A, Cooper-DeHoff RM, Handberg E, Zhou Q, Pepine CJ (2008) Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J

  22. Kristal-Boneh E, Silber H, Harari G, Froom P (2000) The association of resting heart rate with cardiovascular, cancer and all-cause mortality. eight year follow-up of 3527 male israeli employees (the CORDIS Study). Eur Heart J 21:116–124. doi:10.1053/euhj.1999.1741

    Article  CAS  PubMed  Google Scholar 

  23. Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Böhm M (2014) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 103:149–159

    Article  PubMed  Google Scholar 

  24. Mensink G, Hoffmeister H (1997) The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 18:1404–1410

    Article  CAS  PubMed  Google Scholar 

  25. Perskly V, Dyer AR, Leonas J, Stamler J, Berkson DM, Lindberg HA, Paul O, Shekelle RB, Lepper MH, Schoenberger JA (1981) Heart rate: a risk factor for cancer? Am J Epidemiol 114:477–487

    Google Scholar 

  26. Reunanen A, Karjalainen J, Ristola P, Heliövaara M, Knekt P, Aromaa A (2000) Heart rate and mortality. J Intern Med 247:231–239

    Article  CAS  PubMed  Google Scholar 

  27. Saxena A, Minton D, Lee D-c, Sui X, Fayad R, Lavie CJ, Blair SN (2013) Protective role of resting heart rate on all-cause and cardiovascular disease mortality. In: Mayo Clinic Proceedings. Elsevier, p 1420–1426

  28. Stettler C, Bearth A, Allemann S, Zwahlen M, Zanchin L, Deplazes M, Christ E, Teuscher A, Diem P (2007) QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up. Diabetologia 50:186–194

    Article  CAS  PubMed  Google Scholar 

  29. Thomas F, Guize L, Bean K, Benetos A (2001) Pulse pressure and heart rate: independent risk factors for cancer? J Clin Epidemiol 54:735–740

    Article  CAS  PubMed  Google Scholar 

  30. Thomas F, Rudnichi A, Bacri A-M, Bean K, Guize L, Benetos A (2001) Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 37:1256–1261

    Article  CAS  PubMed  Google Scholar 

  31. Wang A, Chen S, Wang C, Zhou Y, Wu Y, Xing A, Luo Y, Huang Z, Liu X, Guo X (2014) Resting heart rate and risk of cardiovascular diseases and all-cause death: the Kailuan study

  32. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF (2013) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: american society of clinical oncology/college of american pathologists clinical practice guideline update. J clin oncol 31:3997–4013. doi:10.1200/jco.2013.50.9984

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2015S1A5B8036349).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Seung Il Kim or Justin Y. Jeon.

Ethics declarations

Conflicts of interest

None declared.

Additional information

Dong Hoon Lee and Seho Park have equally contributed to this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, D.H., Park, S., Lim, S.M. et al. Resting heart rate as a prognostic factor for mortality in patients with breast cancer. Breast Cancer Res Treat 159, 375–384 (2016). https://doi.org/10.1007/s10549-016-3938-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-016-3938-1

Keywords

Navigation